Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154)
Saved in:
| Published in: | Lung Cancer: Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552402963005440 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Lung Cancer: Targets and Therapy |
| description | |
| discipline_display | Respiratory Diseases |
| discipline_facet | Respiratory Diseases |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:58427 |
| institution | FRELIP |
| journal_source_facet | Lung Cancer: Targets and Therapy |
| last_indexed | 2026-06-20T21:19:56.163Z |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) Respiratory Diseases General Respiratory Diseases |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Respiratory Diseases General Respiratory Diseases |
| subject_facet | Respiratory Diseases General Respiratory Diseases |
| title | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) |
| title_alt | LAURA completa el rompecabezas del tratamiento con osimertinib para EGFR+ NSCLC desde el estadio IB al IV: osimertinib adyuvante mejora significativamente la SLP y la progresión del SNC en NSCLC en estadio III no resecable con mutación de EGFR en comparación con placebo (LAURA, NCT03521154) LAURA complète le puzzle du traitement par osimertinib du CBNPC EGFR+ du stade IB au IV : l'osimertinib adjuvant améliore significativement la SSP et la progression du SNC par rapport au placebo dans le CBNPC EGFR muté de stade III non résécable (LAURA, NCT03521154) LAURA Completa o Quebra-Cabeça do Tratamento com Osimertinibe para CPNPC EGFR+ do Estádio IB ao IV: Osimertinibe Adjuvante Melhora Significativamente a SLP e a Progressão no SNC em CPNPC Estádio III Irressecável com Mutação de EGFR Comparado ao Placebo (LAURA, NCT03521154) |
| title_auth | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) |
| title_es_txt | LAURA completa el rompecabezas del tratamiento con osimertinib para EGFR+ NSCLC desde el estadio IB al IV: osimertinib adyuvante mejora significativamente la SLP y la progresión del SNC en NSCLC en estadio III no resecable con mutación de EGFR en comparación con placebo (LAURA, NCT03521154) |
| title_fr_txt | LAURA complète le puzzle du traitement par osimertinib du CBNPC EGFR+ du stade IB au IV : l'osimertinib adjuvant améliore significativement la SSP et la progression du SNC par rapport au placebo dans le CBNPC EGFR muté de stade III non résécable (LAURA, NCT03521154) |
| title_full | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) |
| title_fullStr | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) |
| title_full_unstemmed | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) |
| title_pt_txt | LAURA Completa o Quebra-Cabeça do Tratamento com Osimertinibe para CPNPC EGFR+ do Estádio IB ao IV: Osimertinibe Adjuvante Melhora Significativamente a SLP e a Progressão no SNC em CPNPC Estádio III Irressecável com Mutação de EGFR Comparado ao Placebo (LAURA, NCT03521154) |
| title_short | LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154) |
| title_sort | laura completes the osimertinib treatment jigsaw puzzle of egfr+ nsclc from stage ib to iv: adjuvant osimertinib significantly improves pfs and cns progression in unresectable stage iii egfr-mutated nsclc compared to placebo (laura, nct03521154) |
| topic | Respiratory Diseases General Respiratory Diseases |
| url | https://www.dovepress.com/laura-completes-the-osimertinib-treatment-jigsaw-puzzle-of-egfr-nsclc--peer-reviewed-fulltext-article-LCTT |